Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
作者信息
Gatwood Katie S, Culos Kathryn A, Binari Laura A, Engelhardt Brian G, Kassim Adetola, Byrne Michael T, Goodman Stacey A, Chinratanalab Wichai, Sengsayadeth Salyka M, Greer John P, Jagasia Madan, Savani Bipin N
机构信息
Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
出版信息
Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14.
PMID:29540851
Abstract
摘要
相似文献
1
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14.
2
Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
Int J Hematol. 2016 Apr;103(4):461-8. doi: 10.1007/s12185-016-1960-z. Epub 2016 Feb 24.
3
Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia.
Biol Blood Marrow Transplant. 2005 May;11(5):399-400. doi: 10.1016/j.bbmt.2005.02.007.
4
Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.
Biol Blood Marrow Transplant. 2014 Nov;20(11):1722-8. doi: 10.1016/j.bbmt.2014.06.033. Epub 2014 Jul 10.
5
Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Am J Hematol. 2009 Mar;84(3):167-9. doi: 10.1002/ajh.21355.
6
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
Biol Blood Marrow Transplant. 2016 Aug;22(8):1455-1459. doi: 10.1016/j.bbmt.2016.04.003. Epub 2016 May 8.
7
[Progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia].
Zhonghua Er Ke Za Zhi. 2013 May;51(5):345-8.
8
[Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):221-4. doi: 10.3760/cma.j.issn.0253-2727.2014.03.009.
9
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Curr Res Transl Med. 2017 Sep;65(3):115-119. doi: 10.1016/j.retram.2017.09.001. Epub 2017 Oct 4.
10
Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
Bone Marrow Transplant. 2015 Oct;50(10):1312-5. doi: 10.1038/bmt.2015.153. Epub 2015 Jun 29.
引用本文的文献
1
Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
Bone Marrow Transplant. 2024 Sep;59(9):1275-1279. doi: 10.1038/s41409-024-02323-1. Epub 2024 Jun 15.
2
The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study.
Front Immunol. 2022 Aug 31;13:967026. doi: 10.3389/fimmu.2022.967026. eCollection 2022.
Zotero 插件